UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Stereoselektive Synthese des Nitrit-reduzierenden Cofaktors Häm d1 ausgehend von Hämatoporphyrin

Helvetica chimica acta, 1996-09, Vol.79 (6), p.1572-1586

1996

Volltextzugriff (PDF)

Stereoselektive Synthese des Nitrit‐reduzierenden Cofaktors Häm d 1 ausgehend von Hämatoporphyrin

Helvetica chimica acta, 1996-09, Vol.79 (6), p.1572-1586

1996

Volltextzugriff (PDF)

Stereoselektive Synthese des Nitrit‐reduzierenden Cofaktors Häm d1 ausgehend von Hämatoporphyrin

Helvetica chimica acta, 1996-09, Vol.79 (6), p.1572-1586

1996

Volltextzugriff (PDF)

A convenient synthesis of the nitrite reducing cofactor heme d 1 from hematoporphyrin

Tetrahedron letters, 1992, Vol.33 (6), p.765-768

1992

Volltextzugriff (PDF)

A convenient synthesis of the nitrite reducing cofactor heme d1 from hematoporphyrin

Tetrahedron letters, 1992-02, Vol.33 (6), p.765-768

1992

Volltextzugriff (PDF)

Eine einfache Synthese von Dioxoisobakteriochlorinen aus Hämatoporphyrin

Angewandte Chemie, 1989-04, Vol.101 (4), p.471-473

1989

Volltextzugriff (PDF)

Eine einfache Synthese von Dioxoisobakteriochlorinen aus Hämatoporphyrin

Angewandte Chemie, 1989-04, Vol.101 (4), p.471-473

1989

Volltextzugriff (PDF)

A Simple Synthesis of Dioxoisobacteriochlorins from Hematoporphyrin

Angewandte Chemie (International ed.), 1989-04, Vol.28 (4), p.480-483

1989

Volltextzugriff (PDF)

Summary and derived Risk Assessment of 3D printing emission studies

Atmospheric environment (1994), 2023-02, Vol.294, p.119501, Article 119501

2023

Volltextzugriff (PDF)

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

The lancet oncology, 2012, Vol.13 (1), p.100-110

2012

Volltextzugriff (PDF)

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

The lancet oncology, 2012, Vol.13 (1), p.89-99

2012

Volltextzugriff (PDF)

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

The Lancet infectious diseases, 2016-10, Vol.16 (10), p.1154-1168

2016

Volltextzugriff (PDF)

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

The Lancet (British edition), 2014-12, Vol.384 (9961), p.2213-2227

2014

Volltextzugriff (PDF)

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

The lancet oncology, 2015-07, Vol.16 (7), p.775-786

2015

Volltextzugriff (PDF)

Evaluating Particle Emissions and Toxicity of 3D Pen Printed Filaments with Metal Nanoparticles As Additives: In Vitro and in Silico Discriminant Function Analysis

ACS sustainable chemistry & engineering, 2021-09, Vol.9 (35), p.11724-11737

2021

Volltextzugriff (PDF)

27 Assessing Differences in Academic Achievement Among a National Sample of Children with Epilepsy Before and During the COVID-19 Pandemic

Journal of the International Neuropsychological Society, 2023-11, Vol.29 (s1), p.28-29

2023

Volltextzugriff (PDF)

26 The Importance of Executive Functioning for Academic Achievement Among a National Sample of Children with Epilepsy

Journal of the International Neuropsychological Society, 2023-11, Vol.29 (s1), p.26-27

2023

Volltextzugriff (PDF)

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

The Journal of infectious diseases, 2013-11, Vol.208 (9), p.1391-1396

2013

Volltextzugriff (PDF)

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study

International journal of cancer, 2016-05, Vol.138 (10), p.2428-2438

2016

Volltextzugriff (PDF)

Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study

Human vaccines & immunotherapeutics, 2016-01, Vol.12 (1), p.20-29

2016

Volltextzugriff (PDF)

Leveraging expertise and optimizing clinical research: Initial success of a pediatric epilepsy surgery collaborative

Epilepsia (Copenhagen), 2023-06, Vol.64 (6), p.1554-1567

2023

Volltextzugriff (PDF)

Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases

Expert review of vaccines, 2016-03, Vol.15 (3), p.367-387

2016

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(39)
Reviews
(1)

Sprache

Englisch
(37)
Deutsch
(4)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Stereoselektive Synthese des Nitrit-reduzierenden Cofaktors Häm d1 ausgehend von Hämatoporphyrin

Stereoselektive Synthese des Nitrit‐reduzierenden Cofaktors Häm d 1 ausgehend von Hämatoporphyrin

Stereoselektive Synthese des Nitrit‐reduzierenden Cofaktors Häm d1 ausgehend von Hämatoporphyrin

A convenient synthesis of the nitrite reducing cofactor heme d 1 from hematoporphyrin

A convenient synthesis of the nitrite reducing cofactor heme d1 from hematoporphyrin

Eine einfache Synthese von Dioxoisobakteriochlorinen aus Hämatoporphyrin

Eine einfache Synthese von Dioxoisobakteriochlorinen aus Hämatoporphyrin

A Simple Synthesis of Dioxoisobacteriochlorins from Hematoporphyrin

Summary and derived Risk Assessment of 3D printing emission studies

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study

Evaluating Particle Emissions and Toxicity of 3D Pen Printed Filaments with Metal Nanoparticles As Additives: In Vitro and in Silico Discriminant Function Analysis

27 Assessing Differences in Academic Achievement Among a National Sample of Children with Epilepsy Before and During the COVID-19 Pandemic

26 The Importance of Executive Functioning for Academic Achievement Among a National Sample of Children with Epilepsy

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study

Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study

Leveraging expertise and optimizing clinical research: Initial success of a pediatric epilepsy surgery collaborative

Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases

Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial

Suchergebnisse filtern